why choose us

First received: July 24, 2023

Clinical Trial: Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Cervical Squamous Cell Carcinoma

Study Type: INTERVENTIONAL


Official Title: An Multicenter, Randomized?Double-blind, Controlled Clinical Study of Nimotuzumab in Combined With First-line Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Squamous Cell Ca

Brief Summary: This is an multicenter, randomized?double-blind, controlled clinical study.The purpose of the study is to evaluate the clinical efficacy and safety of Nimotuzumab combined with TP regimen (Paclitaxel + Cisplatin) for treatment of IVB stage, recurrent or persistent cervical squamous cell carcinoma .

Read more